Tubocurarine chloride U.S.P. |
Category:
Description:
Indications:
Contraindications:
Precautions:
-
Pregnancy
category C
-
Only
used by skilled personnel in airway management and respiratory
support.
-
Must
have anticholinesterase reversal agents immediately available during
use.
-
Will
cause histamine release. Use
with caution in patients susceptible to histamine, such as
cardiovascular disease and asthma.
-
May
cause bradycardia during anesthesia.
-
Use
with caution in patients with neuromuscular disease.
-
Use
in caution in elderly due to increased dosage requirements and
recovery times.
-
Does
not alter consciousness or relieve pain.
-
Use
a peripheral nerve stimulator to monitor twitch suppression and
recovery.
-
IM
injection may cause tissue irritation.
Adverse
Reactions (Side Effects):
-
Cardiovascular:
arrhythmias, cardiac arrest, bradycardia, hypotension
-
Excessive
salivation
-
Prolonged
respiratory suppression
|
Dosage:
-
Administered
IV as a sustained injection over 1-1.5 minutes or IM
-
Individualize
dosage calcualted at 0.1-0.2mg/kg
-
General
dosing reference:
-
Adult
(70kg): 40-60 units IV at time of incision, 20-30 units in 3-5
minutes if required
-
long
operations: supplemental doses of 20 units as required (based on
1.1 units/kg)
-
Electroshock
therapy (EST): 1.1 units/kg
-
Myasthenia
gravis diagnosis:
-
administer
1/15 to 1/5 of EST dose
-
exaggerated
response will occur
-
reverse
effect with neostigmine
-
Children:
0.6mg/kg
-
Neonates:
0.3mg/kg
|
|
|
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|